对5-（3'，3'-二甲基-1-三氮烯基）咪唑-4-甲酰胺及其他甲基化试剂具有抗性的人黑色素瘤细胞的特性 - Suppr

Suppr

超能文献

Properties of human melanoma cells resistant to 5-(3',3'-dimethyl-1-triazeno)imidazole-4-carboxamide and other methylating agents.

作者信息

Parsons P G, Smellie S G, Morrison L E, Hayward I P

出版信息

Cancer Res. 1982 Apr;42(4):1454-61.

PMID:7060019

Abstract

摘要

相似文献

Properties of human melanoma cells resistant to 5-(3',3'-dimethyl-1-triazeno)imidazole-4-carboxamide and other methylating agents.对5-（3'，3'-二甲基-1-三氮烯基）咪唑-4-甲酰胺及其他甲基化试剂具有抗性的人黑色素瘤细胞的特性

Cancer Res. 1982 Apr;42(4):1454-61.

Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.Mer表型的人类肿瘤细胞中甲基化剂、羟基脲和甲氨蝶呤的交叉敏感性。

Cancer Res. 1986 Oct;46(10):5009-13.

Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.对甲基化试剂耐药的自体人黑素瘤细胞中病毒再激活、DNA碱基损伤及细胞周期效应的比较

Cancer Res. 1984 Jan;44(1):55-8.

Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺及其代谢产物对诺维科夫肝癌细胞的影响。

Cancer Res. 1976 Aug;36(8):2827-31.

Epigenetic effects of the methylating agent 5-(3-methyl-1-triazeno) imidazole-4-carboxamide in human melanoma cells.甲基化剂5-（3-甲基-1-三氮烯基）咪唑-4-甲酰胺对人黑色素瘤细胞的表观遗传效应。

Aust J Exp Biol Med Sci. 1984 Oct;62 ( Pt 5):597-606. doi: 10.1038/icb.1984.57.

Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).5-(3-甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-407347）的作用，它是一种由5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-45388）衍生而来的烷化剂。

Biochem Pharmacol. 1975 Mar 1;24(5):615-9. doi: 10.1016/0006-2952(75)90182-3.

Cyclophosphamide resistance developed in a human melanoma cell line.一种人黑色素瘤细胞系产生了对环磷酰胺的耐药性。

Cancer Treat Rep. 1984 Oct;68(10):1239-46.

Carcinogenicity of cytostatic triazenes.细胞抑制性三氮烯的致癌性。

IARC Sci Publ. 1986(78):111-26.

5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388).5-（3-羟甲基-3-甲基-1-三氮烯基）咪唑-4-甲酰胺是5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（DIC，DTIC NSC-45388）的一种代谢产物。

Cancer Lett. 1980 Sep;10(3):235-41. doi: 10.1016/0304-3835(80)90076-2.

Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.5-（3-甲基-1-三氮烯基）咪唑-4-甲酰胺（MTIC）对Mer+、Mer+Rem-和Mer-细胞系的细胞毒性：3-乙酰氨基苯甲酰胺的差异增强作用

Br J Cancer. 1988 Jan;57(1):54-8. doi: 10.1038/bjc.1988.8.

引用本文的文献

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells.RAS和BRAF黑色素瘤细胞对抗叶酸药物的化学敏感性差异

Mol Cancer. 2014 Jun 19;13:154. doi: 10.1186/1476-4598-13-154.

Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.人小细胞支气管癌异种移植瘤对烷化剂的诱导抗性和固有抗性

Br J Cancer. 1984 Apr;49(4):431-6. doi: 10.1038/bjc.1984.69.

Development of alkylating agent-resistant human tumor cell lines.耐烷化剂的人类肿瘤细胞系的开发。

Cancer Chemother Pharmacol. 1988;21(4):292-8. doi: 10.1007/BF00264194.

Br J Cancer. 1988 Jan;57(1):54-8. doi: 10.1038/bjc.1988.8.

Clinical pharmacokinetics of high-dose DTIC.大剂量达卡巴嗪的临床药代动力学

Cancer Chemother Pharmacol. 1991;28(6):475-9. doi: 10.1007/BF00685826.

Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma.人肝脏和黑色素瘤中O6-烷基鸟嘌呤DNA烷基转移酶的细胞间和细胞内分布的免疫组织学检查

Br J Cancer. 1992 Aug;66(2):355-60. doi: 10.1038/bjc.1992.270.

In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.使用新型达卡巴嗪类似物CB 10-277治疗的患者淋巴细胞和黑色素瘤中O6-烷基鸟嘌呤-DNA烷基转移酶的体内消耗

Cancer Chemother Pharmacol. 1992;31(3):240-6. doi: 10.1007/BF00685554.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验